ResearcherInsermNo recent work listed

Vincent Drubay

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-6072-7963; OpenAlex author ID A5085253783. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2018: 1 paper

Papers 1

TGF-βRII Knock-down in Pancreatic Cancer Cells Promotes Tumor Growth and Gemcitabine Resistance. Importance of STAT3 Phosphorylation on S727. Co-author DOI 10.3390/cancers10080254 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Nihad Boukrout · 1 shared paper, 2018 · strength 0.08
- Paper TGF-βRII Knock-down in Pancreatic Cancer Cells Promotes Tumor Growth and Gemcitabine Resistance. Importance of STAT3 Ph… DOI 10.3390/cancers10080254 ↗
Nicolas Skrypek · 1 shared paper, 2018 · strength 0.08
- Paper TGF-βRII Knock-down in Pancreatic Cancer Cells Promotes Tumor Growth and Gemcitabine Resistance. Importance of STAT3 Ph… DOI 10.3390/cancers10080254 ↗
Romain Vasseur · 1 shared paper, 2018 · strength 0.08
- Paper TGF-βRII Knock-down in Pancreatic Cancer Cells Promotes Tumor Growth and Gemcitabine Resistance. Importance of STAT3 Ph… DOI 10.3390/cancers10080254 ↗
Isabelle VAN SEUNINGEN · 1 shared paper, 2018 · strength 0.08
- Paper TGF-βRII Knock-down in Pancreatic Cancer Cells Promotes Tumor Growth and Gemcitabine Resistance. Importance of STAT3 Ph… DOI 10.3390/cancers10080254 ↗
Nicolas Jonckheere · 1 shared paper, 2018 · strength 0.08
- Paper TGF-βRII Knock-down in Pancreatic Cancer Cells Promotes Tumor Growth and Gemcitabine Resistance. Importance of STAT3 Ph… DOI 10.3390/cancers10080254 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.